Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Qingfang Li, Yan Tie, Aqu Alu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Oral squamous cell carcinomas: state of the field and emerging directions
Yunhan Tan, Zhihan Wang, Mengtong Xu, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 250
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Rosemary Millen, W. W. B. de Kort, Mandy Koomen, et al.
Med (2023) Vol. 4, Iss. 5, pp. 290-310.e12
Open Access | Times Cited: 48
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives
Nian‐Nian Zhong, Hanqi Wang, Xinyue Huang, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 52-74
Closed Access | Times Cited: 40
Role of E2F transcription factor in oral cancer: Recent insight and advancements
Amal Kassab, Ishita Gupta, Ala‐Eddin Al Moustafa
Seminars in Cancer Biology (2023) Vol. 92, pp. 28-41
Open Access | Times Cited: 34
PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
Francisco Aguayo, Francisco Perez-Dominguez, Julio Osorio, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 22
Joint association of physical activity and dietary quality with survival among US cancer survivors: a population-based cohort study
Xiaoyuan Wei, Yu Min, Zhongzheng Xiang, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 5585-5594
Open Access | Times Cited: 12
Comprehensive Insights into Oral Squamous Cell Carcinoma: Diagnosis, Pathogenesis, and Therapeutic Advances
Dharshini Jagadeesan, Kathiresan V. Sathasivam, Neeraj Kumar Fuloria, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155489-155489
Closed Access | Times Cited: 10
The characterization of tumor immune microenvironment after neoadjuvant immunotherapy in head and neck squamous cell cancer using multiplex immunohistochemistry
Zhaohong An, Xiwei Zhang, Zhaoyang Wang, et al.
Oral Oncology (2025) Vol. 161, pp. 107151-107151
Closed Access | Times Cited: 1
VRK2 promotes colorectal cancer growth and impedes immunotherapy and 5-FU treatment efficacy
Yutong Wu, Meng Gao, Kai Cheng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167729-167729
Closed Access | Times Cited: 1
Therapeutic Approaches with Iron Oxide Nanoparticles to Induce Ferroptosis and Overcome Radioresistance in Cancers
Derek B. Sant’Angelo, Géraldine Descamps, Valentin Lecomte, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 325-325
Open Access | Times Cited: 1
In silico discovery of a novel potential allosteric PI3Kα inhibitor incorporating 2-oxopropyl urea targeting head and neck squamous cell carcinoma
Wenqing Jia, Guangzhuang Li, Xian‐Chao Cheng, et al.
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
Bedanta Bhattacharjee, Ayesha Farhana Syeda, Damanbhalang Rynjah, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods
Pinelopi Samara, Michail Athanasopoulos, Stylianos Mastronikolis, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1482-1482
Open Access | Times Cited: 7
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 7
Head and neck cancer: pathogenesis and targeted therapy
Yan Liu, Nannan Zhang, Yi Wen, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 5
Oral Cancer: Recent Breakthroughs in Pathology and Therapeutic Approaches
Surekha Ramachandran
Oral Oncology Reports (2024), pp. 100678-100678
Open Access | Times Cited: 5
Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer
Hsiu‐Chuan Chang, Cheng‐Chieh Yang, Lai‐Keng Loi, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28406-e28406
Open Access | Times Cited: 4
Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management
Ngoc Ha Tran, Dayna Sais, Nham Tran
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Open Access | Times Cited: 4
Molecular pathways and targeted therapies in head and neck cancers pathogenesis
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
m6A-dependent mature miR-151-5p accelerates the malignant process of HNSCC by targeting LYPD3
Fei Huang, Yuan Ren, Yufei Hua, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Non-coding RNA and drug resistance in head and neck cancer
Yulong Zhang, Yingming Peng, Bingqin Lin, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer
Kateřina Veselá, Zdeněk Kejík, Michal Masařík, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3394-3418
Open Access | Times Cited: 4
MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma
Cuicui Yang, Xiaowu Pang, Shaolei Teng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 588-588
Open Access
Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor‐on‐a‐chip platform
Christian R. Moya‐Garcia, Meghana Munipalle, Alain Pacis, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Page 1 - Next Page

Scroll to top